Washington, D.C., drug

Drug Enforcement Administration. Drug Abuse Warnino Network (DAWN) Phase V. Report. May 1976-Apri 1 1977. Washington, D.C. Drug Enforcement Administration, 1977. p. 152. 

P. Handler, in How Safe is Safe The Design of Policy on Drugs andFood Mdditives, NAS/NRC National Academy Press, Washington, D.C., 1974. 

R. E. WiUette, ed.. Drugs and Driving, NIDA Research Monograph 11, U.S. Department of Health, Education and Welfare, Washington, D.C.,... 

R. Bauer and co-workers ia M. E. Goldhetg, ed., Pharmacological and Biochemical Properties of Drug Suhstances,Yol. 2, Amedcan Pharmaceutical Association, Washington, D.C., 1979, p. 489. A general review on ipratropium bromide. 

T. R. Sweeney, M Survey of Compoundsfrom the Hntiradiation Drug Development Program of the U.S. Army Medical Research and Development Command Walter Reed Army Institute of Research, Washington, D.C., 1979. 

Pood and Dmg Administration, History Office, A Guide to the Resources on the History of the Food and Drug Administration, GPO, Washington, D.C, 1995. 

Code of Federal Regulations, Title 21 Food and Drugs, Part 136, U.S. Government Printing Office, Washington, D.C., Apr. 1991. 

U.S. Pood Drug Administration, Summary of Color Additives Listed for Use in the United States in Food, Drugs, Cosmetics and Medical Devices, Washington, D.C., 1999. 

Commission Directive 95/45/EC, July 26, 1995, laying down specific purity criteria concerning colors for use in foodstuffs. Off. J. Eur. Commun., L226, 22.09.1995. U.S. Food Drug Administration, Summary of color additives listed for use in the United States in food, drugs, cosmetics and medical devices, Washington, D.C., 1999. JECFA, online edition. Combined compendium of food additive specifications, http //WWW. fao. org. 

An Appra i sa1. DHEW Pub. No. (ADM) 79-728 (formerly 78-728). National Institute on Drug Abuse Research Monograph 21. Washington, D.C. Supt. of Docs., U.S. Govt. Print. Off.,... 

Potential problems in PCP abuse were also reported in New Orleans and St. Louis (National Institute on Drug Abuse, in preparation), although the quarterly frequencies of emergency room mentions in those SMSAs were small compared to New York, Washington, D.C., and Los Angeles. 

Perhaps of most significance, we have found that PCP use is relatively common in an arrestee population. Twelve percent of the male arrestees in Manhattan and about 30 percent of arrestees in Washington, D.C. have a urine test positive for PCP. In New York, this would translate into approximately 12,000 PCP-positive persons arrested and processed in Manhattan Central booking each year. Furthermore, these are probably minimum estimates of the number of users, since the urine tests failed to detect the many users who had not taken the drug soon before arrest. 

The fact that PCP is the drug most frequently detected in the urines of arrestees in Washington, D.C., but only the third most frequently detected drug in Manhattan, implies that there may be... 

Forst, B. and Wish, E. Drug use and crime Providing a missing link. In Feinberg, K.R., ed. Violent. Crime in America Washington, D.C. National Policy Exchange, 1983. pp. 84-95. 

It is not uncommon for individuals under the influence of phencyclidine to come to the attention of the criminal justice system. Increasingly, there is a need for forensic experts to advise and testify in cases involving PCP and other psychoactive drugs. With the publication of a paper on acute intoxication and fatalities from PCP use, we began to receive requests from attorneys to evaluate PCP-related cases (Burns et al. 1975). We have now consulted in over 400 civil and criminal cases and have testified in municipal, superior, and Federal courts from Hawaii to Washington, D.C. 

---